Literature DB >> 30652213

A multicentric study on accurate grading of prostate cancer with systematic and MRI/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy.

R Diamand1, M Oderda2, W Al Hajj Obeid3, S Albisinni4, R Van Velthoven3, G Fasolis2, G Simone5, M Ferriero5, J-B Roche6, T Piechaud6, A Pastore7, A Carbone7, G Fiard8, J-L Descotes8, G Marra9, P Gontero9, E Altobelli10, R Papalia10, P Kumar11, D Eldred-Evans12, A Giacobbe13, G Muto13, V Lacetera14, V Beatrici14, T Roumeguere4, A Peltier3.   

Abstract

OBJECTIVE: To evaluate the accuracy in histologic grading of MRI/US image fusion biopsy by comparing histopathology between systematic biopsies (SB), targeted biopsies (TB) and the combination of both (SB + TB) with the final histopathologic outcomes of radical prostatectomy specimens.
MATERIALS AND METHODS: Retrospective, multicentric study of 443 patients who underwent SB and TB using MRI/US fusion technique (Urostation® and Trinity®) prior to radical prostatectomy between 2010 and 2017. Cochran's Q test and McNemar test were conducted as a post hoc test. Uni-multivariable analyses were performed on several clinic-pathological variables to analyze factors predicting histopathological concordance for targeted biopsies.
RESULTS: Concordance in ISUP (International Society of Urological Pathology) grade between SB, TB and SB + TB with final histopathology was 49.4%, 51.2%, and 63.2% for overall prostate cancer and 41.2%, 48.3%, and 56.7% for significant prostate cancer (ISUP grade ≥ 2), respectively. Significant difference in terms of concordance, downgrading and upgrading was found between SB and TB (ISUP grade ≥ 2 only), SB and SB + TB, TB and SB + TB (overall ISUP grade and ISUP grade ≥ 2) (p < 0.001). Total number of cores and previous biopsies were significant independent predictive factors for concordance with TB technique.
CONCLUSION: In this retrospective study, combination of SB and TB significantly increased concordance with final histopathology despite a limited additional number of cores needed.

Entities:  

Keywords:  Biopsy; Concordance; MRI/US fusion; Prostate cancer; Targeted

Mesh:

Year:  2019        PMID: 30652213     DOI: 10.1007/s00345-019-02634-9

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  29 in total

1.  Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial.

Authors:  Panu P Tonttila; Juha Lantto; Eija Pääkkö; Ulla Piippo; Saila Kauppila; Eveliina Lammentausta; Pasi Ohtonen; Markku H Vaarala
Journal:  Eur Urol       Date:  2015-05-29       Impact factor: 20.096

2.  Characteristics of Detected and Missed Prostate Cancer Foci on 3-T Multiparametric MRI Using an Endorectal Coil Correlated With Whole-Mount Thin-Section Histopathology.

Authors:  Nelly Tan; Daniel J Margolis; David Y Lu; Kevin G King; Jiaoti Huang; Robert E Reiter; Steven S Raman
Journal:  AJR Am J Roentgenol       Date:  2015-07       Impact factor: 3.959

3.  Prostate biopsy grading errors: a sampling problem?

Authors:  C R King; J P Long
Journal:  Int J Cancer       Date:  2000-12-20       Impact factor: 7.396

4.  Current trends in patient enrollment for robotic-assisted laparoscopic prostatectomy in Belgium.

Authors:  Simone Albisinni; Steven Joniau; Thierry Quackels; Greet De Coster; Peter Dekuyper; Ben Van Cleynenbreugel; Nancy Van Damme; Elisabeth Van Eycken; Filip Ameye; Thierry Roumeguère
Journal:  Cancer       Date:  2017-07-25       Impact factor: 6.860

5.  Gleason Score Determination with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Guided Prostate Biopsies--Are We Gaining in Accuracy?

Authors:  Camille Lanz; François Cornud; Frédéric Beuvon; Arnaud Lefèvre; Paul Legmann; Marc Zerbib; Nicolas Barry Delongchamps
Journal:  J Urol       Date:  2015-07-10       Impact factor: 7.450

Review 6.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.

Authors:  Jonathan I Epstein; Lars Egevad; Mahul B Amin; Brett Delahunt; John R Srigley; Peter A Humphrey
Journal:  Am J Surg Pathol       Date:  2016-02       Impact factor: 6.394

7.  Current impact of age and comorbidity assessment on prostate cancer treatment choice and over/undertreatment risk.

Authors:  Pierre Lunardi; Guillaume Ploussard; Pascale Grosclaude; Mathieu Roumiguié; Michel Soulié; Jean Baptiste Beauval; Bernard Malavaud
Journal:  World J Urol       Date:  2016-07-21       Impact factor: 4.226

8.  MRI-targeted biopsies versus systematic transrectal ultrasound guided biopsies for the diagnosis of localized prostate cancer in biopsy naïve men.

Authors:  Alexandre Peltier; Fouad Aoun; Marc Lemort; Félix Kwizera; Marianne Paesmans; Roland Van Velthoven
Journal:  Biomed Res Int       Date:  2015-01-27       Impact factor: 3.411

Review 9.  The current and future role of magnetic resonance imaging in prostate cancer detection and management.

Authors:  Jan Philipp Radtke; Dogu Teber; Markus Hohenfellner; Boris A Hadaschik
Journal:  Transl Androl Urol       Date:  2015-06

Review 10.  Systematic review of complications of prostate biopsy.

Authors:  Stacy Loeb; Annelies Vellekoop; Hashim U Ahmed; James Catto; Mark Emberton; Robert Nam; Derek J Rosario; Vincenzo Scattoni; Yair Lotan
Journal:  Eur Urol       Date:  2013-06-04       Impact factor: 20.096

View more
  13 in total

1.  Mri-based cancer lesion analysis with 3d printed patient specific prostate cutting guides.

Authors:  David R Rutkowski; Shane A Wells; Brian Johnson; Wei Huang; David F Jarrard; Joshua M Lang; Steve Cho; Alejandro Roldán-Alzate
Journal:  Am J Clin Exp Urol       Date:  2019-08-15

2.  Selective Bone Scan staging for patients with Prostate cancer: do absolute categories really make sense?

Authors:  Simone Albisinni; Cosimo De Nunzio
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-03-14       Impact factor: 5.554

3.  MRI-targeted biopsy cores from prostate index lesions: assessment and prediction of the number needed.

Authors:  Nick Lasse Beetz; Franziska Dräger; Charlie Alexander Hamm; Seyd Shnayien; Madhuri Monique Rudolph; Konrad Froböse; Sefer Elezkurtaj; Matthias Haas; Patrick Asbach; Bernd Hamm; Samy Mahjoub; Frank Konietschke; Maximilian Wechsung; Felix Balzer; Hannes Cash; Sebastian Hofbauer; Tobias Penzkofer
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-10-08       Impact factor: 5.455

4.  Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical Prostatectomy.

Authors:  Mike Wenzel; Felix Preisser; Clarissa Wittler; Benedikt Hoeh; Peter J Wild; Alexandra Tschäbunin; Boris Bodelle; Christoph Würnschimmel; Derya Tilki; Markus Graefen; Andreas Becker; Pierre I Karakiewicz; Felix K H Chun; Luis A Kluth; Jens Köllermann; Philipp Mandel
Journal:  Diagnostics (Basel)       Date:  2021-05-15

5.  Combined Systematic and MRI-US Fusion Prostate Biopsy Has the Highest Grading Accuracy When Compared to Final Pathology.

Authors:  Iulia Andras; Emanuel Darius Cata; Andreea Serban; Pierre Kadula; Teodora Telecan; Maximilian Buzoianu; Maria Bungardean; Dan Vasile Stanca; Ioan Coman; Nicolae Crisan
Journal:  Medicina (Kaunas)       Date:  2021-05-22       Impact factor: 2.430

6.  MRI-Fusion Targeted vs. Systematic Prostate Biopsy-How Does the Biopsy Technique Affect Gleason Grade Concordance and Upgrading After Radical Prostatectomy?

Authors:  Jessica Rührup; Felix Preisser; Lena Theißen; Mike Wenzel; Frederik C Roos; Andreas Becker; Luis A Kluth; Boris Bodelle; Jens Köllermann; Felix K H Chun; Philipp Mandel
Journal:  Front Surg       Date:  2019-09-18

7.  Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction.

Authors:  Guillaume Ploussard; Jean-Baptiste Beauval; Raphaële Renard-Penna; Marine Lesourd; Cécile Manceau; Christophe Almeras; Jean-Romain Gautier; Guillaume Loison; Daniel Portalez; Ambroise Salin; Michel Soulié; Christophe Tollon; Bernard Malavaud; Mathieu Roumiguié
Journal:  J Clin Med       Date:  2020-01-15       Impact factor: 4.241

8.  Cancer-specific outcomes for prostate cancer patients who had prebiopsy prostate MRI.

Authors:  Jonathan Li; Dattatraya Patil; Martin G Sanda; Christopher P Filson
Journal:  Urol Oncol       Date:  2021-08-02       Impact factor: 3.498

9.  Magnetic Resonance Imaging (MRI)-Targeted Biopsy in Patients with Prostate-Specific Antigen (PSA) Levels <20 ng/mL: A Single-Center Study in Northeastern China.

Authors:  Zhihong Dai; Yangyang Liu; Zhao Huangfu; Liang Wang; Zhiyu Liu
Journal:  Med Sci Monit       Date:  2021-08-08

10.  Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic.

Authors:  Romain Diamand; Guillaume Ploussard; Mathieu Roumiguié; Marco Oderda; Daniel Benamran; Gaelle Fiard; Alexandre Peltier; Giuseppe Simone; Julien Van Damme; Bernard Malavaud; Christophe Iselin; Jean-Luc Descotes; Jean-Baptiste Roche; Thierry Quackels; Thierry Roumeguère; Simone Albisinni
Journal:  World J Urol       Date:  2020-08-10       Impact factor: 3.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.